Rachel Ness, MD
Dermatology · Fargo, NDNPI 1205031713
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by AbbVie at 39.5% of the total. Reporting peaked in 2021 at $3,775 and has fallen 77.9% since, to $833 in 2025.
Across 227 payments — averaging $36.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$888
- Almirall LLC$800
- Revance Therapeutics, Inc.$520
- Johnson & Johnson$483
- Sun Pharmaceutical Industries Inc.$436
- plus $2K from 21 others
What the payments were for
- Consulting fees$80010%
- Speaking & faculty fees$2,68933%
- Food & beverage$4,06050%
- Education$6308%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $3,233 |
| Lilly USA, LLC | 64 | $888 |
| Almirall LLC | 1 | $800 |
| Revance Therapeutics, Inc. | 8 | $520 |
| Johnson & Johnson | 19 | $483 |
| Sun Pharmaceutical Industries Inc. | 14 | $436 |
| Galderma Laboratories, L.p. | 9 | $316 |
| E.r. Squibb & Sons, L.L.C. | 12 | $229 |
| Novartis | 14 | $205 |
| Incyte Corporation | 6 | $125 |
| Regeneron Healthcare Solutions, Inc. | 6 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sanofi | 6 | $94 |
| Pfizer | 5 | $66 |
| Mimedx Group, Inc. | 4 | $66 |
| LEO Pharma Inc. | 4 | $65 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Bristol Myers Squibb | 1 | $65 |
| UCB, Inc. | 2 | $64 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $44 |
| DUSA Pharmaceuticals, Inc. | 2 | $40 |
| Amgen | 2 | $37 |
| Strata Skin Sciences, Inc. | 2 | $31 |
| Merck | 2 | $30 |
| VYNE Pharmaceuticals Inc. | 2 | $28 |
| Dermira, Inc. | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Klisyri$800
How this compares
$8,178 in reported general payments places this provider in the 85th percentile of 29 dermatology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 59 | $2,080 |
| Tacrolimus | 18 | $1,439 |
| Ketoconazole | 65 | $1,371 |
| Clobetasol Propionate | 16 | $983 |
| Doxycycline Hyclate | 25 | $539 |
| Triamcinolone Acetonide | 54 | $531 |
| Mupirocin | 27 | $207 |
| ValacyclovirValacyclovir Hcl | 15 | $189 |
| Hydrocortisone | 21 | $180 |
| Imiquimod | 11 | $178 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fargo
- Michael BlankinshipFargo$130K
- Amanda BeehlerFargo$2K
- Natalie KollmanFargo$2K
- Matthew JohnsonFargo$2K
- Beth HonlFargo$625
- Burton BelknapFargo$547
- Thomas MatzkeFargo$294
- Chetan MaingiFargo$227
- Dong Joo KimFargo$165
- Kimberly KellyFargo$130
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.